Diabetes care and clinical chemistry diagnostic equipment manufacturer
ARKRAY USA manufactures blood glucose meters, HbA1c analyzers, and clinical chemistry equipment for diabetes and long-term care settings. The hiring mix is heavily skewed toward sales (14 of 24 open roles), with minimal engineering and manufacturing headcount — a signal that growth is being driven by market expansion and private-label partnerships rather than product redesign. Pain points around FDA compliance, HIPAA, and inventory management suggest the company is navigating regulatory complexity while scaling distribution.
ARKRAY USA is a Minneapolis-based manufacturer of in vitro diagnostic devices and diabetes care products, operating across blood glucose monitoring, HbA1c analysis, urine chemistry, and clinical diagnostic categories. The company also manufactures private-label blood glucose meters for major retailers. Founded in 1960, ARKRAY operates a 51–200-person organization that balances product development, sales expansion, and healthcare regulatory compliance. The tech stack is predominantly enterprise operational software (Salesforce, Paycom, Sage, Qlik, Power BI) with minimal AI or automation adoption, reflecting a hardware-and-compliance-first business model.
ARKRAY manufactures diabetes care products (blood glucose meters, HbA1c analyzers), clinical chemistry equipment, and urine analyzers for healthcare and long-term care facilities. The company also supplies private-label blood glucose meters to major retailers.
FDA regulatory compliance and HIPAA requirements are documented pain points. The company is actively managing inventory levels, cost controls, and expanding into new territories while maintaining healthcare standards.
Other companies in the same industry, closest in size